Dechert's Hood on Navigating the Uncertainties of Brexit(Audio)
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Andrew Hood, Senior Director and Barrister-at-Law of Dechert LLP in London and former legal advisor to UK Prime Minister Cameron, on...
1 Heinä 201611min
Cumberland's Burgess on Puerto Rico Defaulting on Debt (Audio)
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Shaun Burgess, Portfolio Manager and Analyst, Fixed Income, at Cumberland Advisors, on Puerto Rico defaulting on their debt and what...
1 Heinä 201611min
ISM's Holcomb: All Indices Pointing in Right Direction (Audio)
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Brad Holcomb, Chairman of the Manufacturing Business Survey at the Institute for Supply Management, on the June ISM report.See omnys...
1 Heinä 20168min
Author Jake Bright on Race for E-Commerce Into Africa (Audio)
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Jake Bright, Whitehead Fellow of the Foreign Policy Association, and author of "The Next Africa," on eBay moving into Africa, e-comm...
30 Kesä 20168min
Bloomberg's Wilson on Winners, Losers, Stock of the Day (Audio)
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. Guest: Bloomberg stocks editor David Wilson on today's market winners, losers, and Stock of the Day: Pier 1 Imports (PIR).See omnystudio.co...
30 Kesä 201612min
Geneva's Gimbel: 2017 Will Be Very Good Year for Stocks (Audio)
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Don Gimbel, Portfolio Manager at Geneva Investment Management of Chicago, on how to invest in these unusual times.See omnystudio.com...
30 Kesä 201611min
Alston & Bird's Shimp on Trade Issues Surrounding Brexit(Audio)
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Eric Shimp, policy advisor in Alston & Bird’s International Trade & Regulatory Group, outlines the trade issues surrounding Brexit a...
30 Kesä 201611min
OPKO's Bishop on FDA Approval Of Its Kidney Disease Drug(Audio)
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Dr. Charles Bishop, CEO of OPKO Health Renal Division, to discuss the FDA’s approval of Rayaldee and the health issues surrounding c...
30 Kesä 20168min
